Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features.
Saved in:
| Title: | Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features. |
|---|---|
| Authors: | Gangaev A; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Ketelaars SLC; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Isaeva OI; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Patiwael S; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Dopler A; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Hoefakker K; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., De Biasi S; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy., Gibellini L; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy., Mussini C; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy., Guaraldi G; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy., Girardis M; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy., Ormeno CMPT; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, South Holland, The Netherlands., Hekking PJM; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, South Holland, The Netherlands., Lardy NM; Department of Immunogenetics, Sanquin Diagnostics B.V., Amsterdam, North Holland, The Netherlands., Toebes M; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Balderas R; Department of Biological Sciences, BD Biosciences, San Jose, CA, USA., Schumacher TN; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Ovaa H; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, South Holland, The Netherlands., Cossarizza A; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy., Kvistborg P; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands. p.kvistborg@nki.nl. |
| Source: | Nature communications [Nat Commun] 2021 May 10; Vol. 12 (1), pp. 2593. Date of Electronic Publication: 2021 May 10. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33972535 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Identification and characterization of a SARS-CoV-2 specific CD8<superscript>+</superscript> T cell response with immunodominant features. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gangaev+A%22">Gangaev A</searchLink>; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ketelaars+SLC%22">Ketelaars SLC</searchLink>; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Isaeva+OI%22">Isaeva OI</searchLink>; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Patiwael+S%22">Patiwael S</searchLink>; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dopler+A%22">Dopler A</searchLink>; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hoefakker+K%22">Hoefakker K</searchLink>; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22De+Biasi+S%22">De Biasi S</searchLink>; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy.<br /><searchLink fieldCode="AU" term="%22Gibellini+L%22">Gibellini L</searchLink>; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy.<br /><searchLink fieldCode="AU" term="%22Mussini+C%22">Mussini C</searchLink>; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy.<br /><searchLink fieldCode="AU" term="%22Guaraldi+G%22">Guaraldi G</searchLink>; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy.<br /><searchLink fieldCode="AU" term="%22Girardis+M%22">Girardis M</searchLink>; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy.<br /><searchLink fieldCode="AU" term="%22Ormeno+CMPT%22">Ormeno CMPT</searchLink>; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, South Holland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hekking+PJM%22">Hekking PJM</searchLink>; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, South Holland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lardy+NM%22">Lardy NM</searchLink>; Department of Immunogenetics, Sanquin Diagnostics B.V., Amsterdam, North Holland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Toebes+M%22">Toebes M</searchLink>; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Balderas+R%22">Balderas R</searchLink>; Department of Biological Sciences, BD Biosciences, San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Schumacher+TN%22">Schumacher TN</searchLink>; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ovaa+H%22">Ovaa H</searchLink>; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, South Holland, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Cossarizza+A%22">Cossarizza A</searchLink>; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy.<br /><searchLink fieldCode="AU" term="%22Kvistborg+P%22">Kvistborg P</searchLink>; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands. p.kvistborg@nki.nl. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2021 May 10; Vol. 12 (1), pp. 2593. <i>Date of Electronic Publication: </i>2021 May 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33972535 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-021-22811-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2593 Titles: – TitleFull: Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gangaev A – PersonEntity: Name: NameFull: Ketelaars SLC – PersonEntity: Name: NameFull: Isaeva OI – PersonEntity: Name: NameFull: Patiwael S – PersonEntity: Name: NameFull: Dopler A – PersonEntity: Name: NameFull: Hoefakker K – PersonEntity: Name: NameFull: De Biasi S – PersonEntity: Name: NameFull: Gibellini L – PersonEntity: Name: NameFull: Mussini C – PersonEntity: Name: NameFull: Guaraldi G – PersonEntity: Name: NameFull: Girardis M – PersonEntity: Name: NameFull: Ormeno CMPT – PersonEntity: Name: NameFull: Hekking PJM – PersonEntity: Name: NameFull: Lardy NM – PersonEntity: Name: NameFull: Toebes M – PersonEntity: Name: NameFull: Balderas R – PersonEntity: Name: NameFull: Schumacher TN – PersonEntity: Name: NameFull: Ovaa H – PersonEntity: Name: NameFull: Cossarizza A – PersonEntity: Name: NameFull: Kvistborg P IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 05 Text: 2021 May 10 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 12 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |